HealthCare Global Enterprises Limited (HCG.BO)
HealthCare Global Enterprises Limited operates in the Medical - Care Facilities industry of the Healthcare sector, headquartered in Bengaluru, KA, IN. The stock last traded at $713.90, down 1.04% on the session, giving a market capitalisation of $107.86B. Its beta of -0.07 implies it has historically moved less than the broad market.
HealthCare Global Enterprises Limited (HCG), along with its subsidiaries, delivers specialized healthcare services with a primary emphasis on oncology and fertility. The company's cancer division provides comprehensive care, encompassing diagnosis and various treatment modalities such as radiation therapy, medical oncology, and surgical interventions. For fertility services, HCG operates under the Milann brand, offering a range of treatments and reproductive medicine solutions, including assisted reproduction, gynecological endoscopy, and fertility preservation. Beyond these core specializations, HCG also manages multi-specialty hospitals under its own brand. These facilities are located in Ahmedabad, Bhavnagar, and Rajkot within the state of Gujarat. Additionally, the company holds an operations and management contract for a hospital in Hubli, Karnataka, which offers diverse medical services including cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, pulmonology, and critical care. The company further extends its services to medical diagnostics, offering scientific testing and consultancy to the pharmaceutical and broader medical sectors. HealthCare Global Enterprises, founded in 1989, maintains its headquarters in Bengaluru, India, and operates numerous dedicated cancer centers.
HealthCare Global Enterprises Limited is most often compared with the following Healthcare names: